
Editors-in-chief: Edith A. Perez, MD & Dr. Miguel Martín
Dr. Pere Gascón selected the most recently published information by ASCO on the advances in the management of the Lung CRC and they evaluate their impact on daily clinical practice. Recent information is offered on Genetics and Epigenetics, Tumor markers, management of early, locally advanced and metastatic disease, new molecular targets and new treatments. This extraordinary and recently updated self-assessment program is offered in a collection of three volumes. Self-Assessment questions are included at the end of each volume.